Skip to main content

IDT Licenses Dual-labeled Probe Technology from ABI

NEW YORK (GenomeWeb News) – Nucleic acids supplier Integrated DNA Technologies has inked an agreement with Applied Biosystems giving it the rights to sell dual-labeled probes for real-time PCR, IDT said today.
 
Under the license, IDT has gained rights to “several probe composition and method patents,” and to US Patent No. 5,804,375, giving it the rights to make and sell the custom probes and primers in “assay-ready” formats.
 
Coralville, Iowa-based IDT said the agreement allows its academic, government, and corporate customers to buy probes from IDT for use in the 5’ Nuclease Assay. IDT also said it is the first company to sign such an agreement under ABI’s Probe Manufacturing License Program.
 
Researchers currently buy probes and primers in separate tubes and often from separate vendors, IDT said. This agreement allows it to offer these researchers design services for probes and primers for this assay, and to supply them in a “more convenient, ready-to-use format,” the company said.
 
“The agreement also opens new markets for our existing probe products, and opens doors for IDT to develop new products, which we hope to launch in the near future,” IDT Senior VP and General Counsel Roman Terrill said in a statement.
 
Financial terms of the agreement were not released.

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.